Sanofi Leans On Biopharm Firm Medivation To Take $9.3B Bid
French drugmaker Sanofi S.A. went public Thursday with an all-cash $9.3 billion offer in its hard-driving buyout bid for biopharmaceutical firm Medivation Inc., which responded that its board is already aware...To view the full article, register now.
Already a subscriber? Click here to view full article